BackOrthofix Medical Overview

Orthofix Medical Profit Margin

Latest profit margin for Orthofix Medical: -7.41% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-7.49%
8.04% YoY

As of Jun 2026

Annual Profit Margin (TTM)

-7.41%
51.55% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Orthofix Medical (OFIX) FAQ

The latest profit margin for OFIX is -7.41% as of June 2026. That compares with -15.29% in the prior-year period — up 51.6% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Orthofix Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, OFIX's profit margin moved from -15.29% to -7.41% — a 51.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Orthofix Medical's valuation or profitability profile.

Against Healthcare companies, OFIX currently prints -7.41% for profit margin, while the sector average sits near 13.89%. That is roughly 153.3% below the sector mean. Large gaps often invite a closer look at Orthofix Medical's growth, margins, and balance sheet.

Profit Margin shows how effectively Orthofix Medical converts resources into returns. At -7.41%, OFIX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -15.29% in the prior-year period — up 51.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting OFIX's profit margin (-7.41%), review year-over-year change from -15.29%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.